Type III Collagen Glomerulopathy
Helen Liapis, MD
Joseph Gaut, MD, PhD
Key Facts
Terminology
-
Idiopathic glomerular disease defined by accumulation of mesangial and subendothelial type III collagen
Clinical Issues
-
Rare (< 0.1% of biopsies)
-
Presents with hematuria or proteinuria
-
Hemolytic uremic syndrome, children
-
Variable disease course
-
Increased serum and urine procollagen III peptide
Microscopic Pathology
-
Lobular glomeruli without inflammation
-
Thickened capillary walls
-
Mesangial and capillary wall expansion with eosinophilic, silver-positive material
-
Electron microscopy
-
Mesangial and subendothelial curvilinear fibrils
-
Fibers tend to be frayed and curved, ˜ 60 nm periodicity
-
-
Immunohistochemical staining for type III collagen positive in mesangium and GBM
Top Differential Diagnoses
-
Nail-patella syndrome
-
Hereditary multiple exostoses
-
Fibronectin glomerulopathy
-
Fibrillary glomerulopathy
Diagnostic Checklist
-
Diagnosis made by demonstration of collagen III in glomeruli
TERMINOLOGY
Synonyms
-
Collagenofibrotic glomerulopathy
Definitions
-
Idiopathic glomerular disease defined by accumulation of mesangial and subendothelial type III collagen
-
Initially described by Arakawa and colleagues in 1979
ETIOLOGY/PATHOGENESIS
Proposed Etiologies
-
Probably systemic disease of collagen metabolism
-
Increased level of N-terminal procollagen type III in blood
-
Indicative of increased synthesis/catabolism
-
Deposit in glomeruli
-
Excreted in urine
-
-
-
Occasional cases in siblings suggest a genetic component, as yet unidentified
-
Some believe this is a primary disease of the glomerulus
CLINICAL ISSUES
Epidemiology
-
Incidence
-
Rare (˜ 0.1% of biopsies)
-
-
Age
-
All ages
-
-
Gender
-
M:F = 1:1
-
-
Ethnicity
-
Majority of reported cases are Japanese
-
Cases also reported in USA, Europe, India, South America, China
-
Presentation
-
Microhematuria
-
Hypertension
-
Edema
-
Proteinuria, nephrotic range in 60%
-
Anemia
-
Adults typically have anemia of chronic disease
-
Children occasionally present with thrombotic microangiopathy
-
-
Hemolytic uremic syndrome, children
Laboratory Tests
-
10-100x increase in serum and urine N-terminal procollagen type III peptide (PIIINP)
Treatment
-
Drugs
-
No specific treatment
-
Steroid therapy is reported to slow disease progression
-
Prognosis
-
Variable disease course, limited data
-
˜ 35% of adults and ˜ 90% of children progress to end-stage renal failure
-
MICROSCOPIC PATHOLOGY
Histologic Features
-
Glomeruli
-
Lobular or mesangial hypercellularity, variable
-
Nodular pattern at times resembles diabetic glomerulopathy
-
-
Expansion of mesangium with eosinophilic, silver-positive material
-
Thickening of GBM
-
Occasional double contours
-
-
Closure of capillary loops
-
No inflammation
-
-
No specific changes in tubules, interstitium, or vessels
ANCILLARY TESTS
Immunohistochemistry

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

